Allison Yoshimoto, MS, CCC-SLP | |
122 Anamuli Street, Kahului, HI 96732 | |
(808) 359-4233 | |
Not Available |
Full Name | Allison Yoshimoto |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 122 Anamuli Street, Kahului, Hawaii |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396118311 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | SP-887 (Hawaii) | Primary |
Mailing Address | Practice Location Address |
---|---|
Allison Yoshimoto, MS, CCC-SLP 122 Anamuli Street, Kahului, HI 96732 Ph: (808) 359-4233 | Allison Yoshimoto, MS, CCC-SLP 122 Anamuli Street, Kahului, HI 96732 Ph: (808) 359-4233 |
News Archive
In accordance with the World Health Organization recommendation of optimal infant feeding practices, and as interpreted in policy documents of the American Academy of Pediatrics, American College of Obstetrics and Gynecology, Academy of Breastfeeding Medicine, Academy of Nutrition and Dietetics, it is the position of The Obesity Society that women should be encouraged and supported to exclusively breastfeed for approximately the first six months of an infant's life with continued breastfeeding through the infant's first year and beyond as age-appropriate complementary foods are introduced and as mutually desired by the mother and child.
BrainLAB, a manufacturer of software-driven systems for targeted, less-invasive medical treatments, announced today that St. Luke's Hospital in Cedar Rapids, Iowa, has acquired VectorVision® flex, a powerful computer-assisted surgery (CAS) system featuring Digital Lightbox© with TraumaCad(TM), a pre-operative planning and digital templating software solution.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line results from its IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials, the phase III studies that assessed XIAFLEX (collagenase clostridium histolyticum or CCH), a novel, in-office, first-in-class biologic therapy for the potential treatment of Peyronie's disease (PD).
Abbott today announced it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the next-generation XIENCE PRIME Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.
Young people and women are identified as target groups to aim tobacco packaging at according to a new Cancer Research UK report released on Thursday.
› Verified 6 days ago
Carley Jeanette Stone, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 161 S Wakea Ave, Kahului, HI 96732 Phone: 808-244-7467 | |
Jill D Sexton, SP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 472 Kaulana St, Kahului, HI 96732 Phone: 808-877-2761 | |
Ms. Rachel Fielder, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 472 Kaulana St, Kahului, HI 96732 Phone: 808-877-2761 | |
Ms. Adrienne Celine San Diego Cruz, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 161 S Wakea Ave, Kahului, HI 96732 Phone: 808-244-7467 | |
Tami R Yamamura, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 795 Onehee Ave, Kahului, HI 96732 Phone: 808-727-4200 | |
Jennifer Lee, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 169 Maa St Ste C, Kahului, HI 96732 Phone: 808-793-7343 |